140 related articles for article (PubMed ID: 9476123)
1. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface.
Larsson R; Elgue G; Larsson A; Ekdahl KN; Nilsson UR; Nilsson B
Immunopharmacology; 1997 Dec; 38(1-2):119-27. PubMed ID: 9476123
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
[TBL] [Abstract][Full Text] [Related]
4. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
Nilsson B; Larsson R; Hong J; Elgue G; Ekdahl KN; Sahu A; Lambris JD
Blood; 1998 Sep; 92(5):1661-7. PubMed ID: 9716594
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
6. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model.
Gong J; Larsson R; Ekdahl KN; Mollnes TE; Nilsson U; Nilsson B
J Clin Immunol; 1996 Jul; 16(4):222-9. PubMed ID: 8840224
[TBL] [Abstract][Full Text] [Related]
7. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin.
Hong J; Nilsson Ekdahl K; Reynolds H; Larsson R; Nilsson B
Biomaterials; 1999 Apr; 20(7):603-11. PubMed ID: 10208402
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass.
Finn A; Morgan BP; Rebuck N; Klein N; Rogers CA; Hibbs M; Elliott M; Shore DF; Evans TW; Strobel S; Moat N
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):451-9. PubMed ID: 8583820
[TBL] [Abstract][Full Text] [Related]
9. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
Bexborn F; Engberg AE; Sandholm K; Mollnes TE; Hong J; Nilsson Ekdahl K
J Biomed Mater Res A; 2009 Jun; 89(4):951-9. PubMed ID: 18470919
[TBL] [Abstract][Full Text] [Related]
10. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
[TBL] [Abstract][Full Text] [Related]
11. Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.
Hamad OA; Mitroulis I; Fromell K; Kozarcanin H; Chavakis T; Ricklin D; Lambris JD; Ekdahl KN; Nilsson B
Thromb Haemost; 2015 Nov; 114(6):1207-17. PubMed ID: 26293614
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
Rinder C; Fitch J
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
[TBL] [Abstract][Full Text] [Related]
13. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.
Fiane AE; Mollnes TE; Videm V; Hovig T; Høgåsen K; Mellbye OJ; Spruce L; Moore WT; Sahu A; Lambris JD
Xenotransplantation; 1999 Feb; 6(1):52-65. PubMed ID: 10355733
[TBL] [Abstract][Full Text] [Related]
14. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
15. Role of C3 cleavage in monocyte activation during extracorporeal circulation.
Rinder CS; Rinder HM; Johnson K; Smith M; Lee DL; Tracey J; Polack G; Higgins P; Yeh CG; Smith BR
Circulation; 1999 Aug; 100(5):553-8. PubMed ID: 10430771
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface.
De Somer F; François K; van Oeveren W; Poelaert J; De Wolf D; Ebels T; Van Nooten G
Eur J Cardiothorac Surg; 2000 Nov; 18(5):602-6. PubMed ID: 11053824
[TBL] [Abstract][Full Text] [Related]
18. APT070 inhibits complement activation during in vitro cardiopulmonary bypass.
De Silva RJ; Vuylsteke A; Fritchley SJ; Trull AK; Dunning JJ; Wallwork J
Eur J Cardiothorac Surg; 2006 Jul; 30(1):72-6. PubMed ID: 16723247
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass.
Moen O; Høgåsen K; Fosse E; Dregelid E; Brockmeier V; Venge P; Harboe M; Mollnes TE
Ann Thorac Surg; 1997 Jan; 63(1):105-11. PubMed ID: 8993250
[TBL] [Abstract][Full Text] [Related]
20. Platelet adhesion onto artificial surfaces: inhibition by benzamidine, pentamidine, and pyridoxal-5-phosphate as demonstrated by flow cytometric quantification of platelet adhesion to microspheres.
Gemmell CH
J Lab Clin Med; 1998 Jan; 131(1):84-92. PubMed ID: 9452131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
